Scroll down to read all the latest news articles, press releases, and interviews.
Looking for our Public Announcements? Head on over to our announcements page in the Investor Centre
ASX/NZX AnnouncementsMarket research company, Pitt Street, released its updated report on TruScreen.
ViewTruscreen Group Limited announced its intention to launch a 1 for 5 pro-rata renounceable rights issue to raise up to circa $2.2 million ("Rights Offer”) on 17 February 2023. The…
ViewASX Article | Wed 08 February 2023 | Tony Featherstone Move turns spotlight on medtech’s cervical-cancer screening device.
ViewThe Zimbabwe National AIDS Council (NAC) wrapped up its current TruScreen pilot program in January. 10,000+ women were screened during the 6-month pilot. For many of these women this is…
ViewAt the end of 2022, TruScreen’s Mexican distributor in conjunction with a local foundation brought TruScreen screening to vulnerable young women.
ViewTruScreen’s Commercial GM travelled to Vietnam in late 2022 as boarders reopen and pandemic pressures begin to ease.
ViewTruScreen's Mexican distributor, Sunbird, continues their local marketing efforts with a TruScreen booth at the 70th Congress of Mexican Gynaecology and Obstetrics in Guadalajara.
ViewTruScreen Group Limited recently presented at the Emerging ASX Gems Investment Conference by The Capital Network. Watch a recording of the presentation here.
ViewNZX/ASX Announcement 15 December 2021 TruScreen Group Limited (NZX/ASX: TRU) (‘TruScreen’ or ‘the Company’) is pleased to provide a market update, outlining the Company’s progress in several of its key…
ViewTruScreen Group Limited's (NZX/ASX: TRU) CEO Juliet Hull sits down with MarketLit's host Lelde Smits to discuss the TruScreen technology, eliminating cervical cancer and TruScreen's 2022 outlook.
ViewTime to Catch Up is this year’s National Cervical Cancer Awareness Week’s theme. With the uncertainty and ongoing impacts from the COVID-19 pandemic, more women have fallen behind in keeping…
View